Peptide GSK−3β inhibitor reduces inflammation and promotes neuroprotection and behavioural recovery in Alzheimer's disease model mice; WβC‐AC involvement to be elucidated. Here, GSK3B is linked to early-onset autosomal dominant Alzheimer disease.